Agilent Technologies, Inc. $A Shares Sold by Mitsubishi UFJ Trust & Banking Corp

Mitsubishi UFJ Trust & Banking Corp lowered its holdings in Agilent Technologies, Inc. (NYSE:A) by 4.0% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 156,936 shares of the medical research company’s stock after selling 6,524 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp’s holdings in Agilent Technologies were worth $18,520,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. SBI Securities Co. Ltd. raised its holdings in Agilent Technologies by 18.5% in the 2nd quarter. SBI Securities Co. Ltd. now owns 1,695 shares of the medical research company’s stock valued at $200,000 after buying an additional 265 shares during the period. Robeco Schweiz AG increased its position in shares of Agilent Technologies by 9.3% during the second quarter. Robeco Schweiz AG now owns 1,204,787 shares of the medical research company’s stock valued at $142,177,000 after acquiring an additional 102,072 shares during the last quarter. CENTRAL TRUST Co raised its stake in shares of Agilent Technologies by 3.7% in the 2nd quarter. CENTRAL TRUST Co now owns 2,522 shares of the medical research company’s stock valued at $298,000 after acquiring an additional 89 shares during the period. Vise Technologies Inc. acquired a new position in shares of Agilent Technologies in the 2nd quarter worth approximately $429,000. Finally, Generation Investment Management LLP lifted its holdings in shares of Agilent Technologies by 15.9% in the 2nd quarter. Generation Investment Management LLP now owns 5,775,860 shares of the medical research company’s stock worth $681,609,000 after acquiring an additional 792,304 shares during the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on A shares. UBS Group upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and lifted their target price for the company from $130.00 to $170.00 in a report on Wednesday, October 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Agilent Technologies in a research note on Wednesday, October 8th. Barclays boosted their price objective on Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a report on Thursday, October 2nd. Rothschild & Co Redburn assumed coverage on Agilent Technologies in a report on Wednesday, October 8th. They set a “buy” rating and a $165.00 target price for the company. Finally, TD Cowen boosted their price target on shares of Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a research note on Tuesday, October 14th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $149.62.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 12,490 shares of the stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $150.00, for a total value of $1,873,500.00. Following the sale, the chief executive officer directly owned 33,448 shares of the company’s stock, valued at approximately $5,017,200. This represents a 27.19% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 0.26% of the stock is owned by company insiders.

Agilent Technologies Trading Up 0.0%

A opened at $146.90 on Friday. The business has a fifty day moving average price of $137.63 and a 200 day moving average price of $123.77. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84. The stock has a market capitalization of $41.65 billion, a price-to-earnings ratio of 34.48, a PEG ratio of 4.67 and a beta of 1.29.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter last year, the company earned $1.32 EPS. Agilent Technologies’s revenue for the quarter was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th were paid a $0.248 dividend. The ex-dividend date was Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s payout ratio is currently 23.24%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.